VITRAC Initiates PI Trial with VIC-1911 and G12C Inhibitor Sotorasib
24 Jan 2023 //
BUSINESSWIRE
VITRAC Initiates a PI/II Trial with Aurora Kinase A inhibitor VIC-1911 in GvHD
26 Apr 2022 //
BUSINESSWIRE
24 Jan 2023 //
BUSINESSWIRE
26 Apr 2022 //
BUSINESSWIRE